Malignant mediastinal lymphadenopathy detected by staging EUS in patients with pancreaticobiliary cancer

MML is detected by staging EUS-FNA in 5% of patients with pancreaticobiliary cancer. Because of its important implications, endosonographers should routinely assess for MML in patients who undergo staging EUS for pancreaticobiliary malignancy.